ET
OLMA icon

Entropy Technologies’s Olema Pharmaceuticals OLMA Stock Holding History

Entropy Technologies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,773
Closed -$235K – 1152
2026
Q1 		$235K Sell
15,773
-1,531
-9% -$34.1K 0.01% 760
2025
Q4 		$433K Buy
+17,304
New +$308K 0.02% 597
2024
Q2 		– Sell
-14,246
Closed -$161K – 864
2024
Q1 		$161K Buy
+14,246
New +$184K 0.02% 667

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Entropy Technologies's OLMA Position: Q2 2026 in Review

Entropy Technologies sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 15,773 shares — an estimated $235K sold.

Entropy Technologies first reported a position in OLMA in Q1 2024 and held it in 3 quarters. The position peaked at $433K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Entropy Technologies reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Entropy Technologies sold 15,773 Olema Pharmaceuticals shares in Q2 2026, an estimated $235K.
  • Entropy Technologies first reported a position in Olema Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Entropy Technologies's Olema Pharmaceuticals position peaked at $433K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.